VRTX - Vertex Pharmaceuticals Incorporated

Healthcare - Sector
Coverage

VRTX is currently covered by 24 analysts with average potential upside of $32.74 (20.06%) backed by 406 price targets and 484 ratings. Analyst's average stock valuation to be materialised ratio is 89.75% with an average time for price targets to be met of 273.79 days.

Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 24-Jan-2023.

Highest price target for VRTX is 314, Lowest price target is 180, average price target is 247.

Split History since 2000:

8/24/00 2 for 1

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

286

$-35.45 (-11.03%)

285

5 days ago

26/31 (83.87%)

$15.17 (10.75%)

265

Hold

296

$-25.45 (-7.92%)

293

10 days ago

27/33 (81.82%)

$20.85 (12.32%)

147

Hold

374

$52.55 (16.35%)

265

12 days ago

8/11 (72.73%)

$15.74 (6.20%)

257

Hold

335

1 months 10 days ago

30/33 (90.91%)

$31.15 (21.53%)

304

Buy

340

$18.55 (5.77%)

280

2 months 12 days ago

8/9 (88.89%)

$28.01 (13.05%)

243

Show more analysts